ipharmaservicesJun 7, 2020Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit
ipharmaservicesJun 6, 2020Taltz was approved in the U.S. for non-radiographic axial spondyloarthritis
ipharmaservicesJun 4, 2020May witnessed the approval of Pfizer’s Talzenna, Nyprax’s Tukysa, Drug Houses’ Ajovy in Singapore
ipharmaservicesJun 3, 2020Sanofi’s Sarclisa approved in Europe for relapsed and refractory multiple myeloma